Agenus Inc - Oct 19, 2021 Form 4 Insider Report for MiNK Therapeutics, Inc. (INKT)

Role: 10%+ Owner
Signature: /s/ Christine Klaskin, Vice President, Finance
Stock symbol: INKT
Transactions as of: Oct 19, 2021
Transactions value $: $16,800,000
Form type: 4
Date filed: 10/20/2021, 07:37 PM
Previous filing: Oct 20, 2021
Next filing: May 26, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INKT	Common Stock	Purchase	$16.8M	+1.4M	+7.19%	$12.00^*	20.9M	Oct 19, 2021	Direct	F1
transaction	INKT	Common Stock	Conversion of derivative security		-5.45M	-17.15%		26.3M	Oct 19, 2021	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INKT	Convertible Promissory Note	Conversion of derivative security		-5.45M	-100%		0	Oct 19, 2021	Common Stock	5.45M		Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were purchased in this Issuer's initial public offering.
F2	The shares were received upon the automatic conversion of a convertible promissory note issued to Agenus Inc. by the issuer upon completion of the Issuer's initial public offering. The conversion rate of the note was equal to the quotient obtained by dividing (i) the amount due on the date of conversion by (ii) 80% of the per share price of the common stock sold in the initial public offering.